Browse > Article
http://dx.doi.org/10.3344/kjp.2011.24.1.1

Application of Botulinum Toxin in Pain Management  

Sim, Woo-Seog (Department of Anesthesiology and Pain Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Publication Information
The Korean Journal of Pain / v.24, no.1, 2011 , pp. 1-6 More about this Journal
Abstract
Botulinum toxin has been used for the treatment of many clinical disorders by producing temporary skeletal muscle relaxation. In pain management, botulinum toxin has demonstrated an analgesic effect by reducing muscular hyperactivity, but recent studies suggest this neurotoxin could have direct analgesic mechanisms different from its neuromuscular actions. At the moment, botulinum toxin is widely investigated and used in many painful diseases such as myofascial syndrome, headaches, arthritis, and neuropathic pain. Further studies are needed to understand the exact analgesic mechanisms, efficacy and complications of botulinum toxin in chronic pain disorders.
Keywords
botulinum toxin; pain;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Freund BJ, Schwartz M. Use of botulinum toxin in chronic whiplash-associated disorder. Clin J Pain 2002; 18(Suppl 6): S163-8.   DOI
2 Mahowald ML, Krug HE, Singh JA, Dykstra D. Botulinum toxin for osteoarticular pain. In: Botulinum toxin. Therapeutic clinical practice and science. Edited by Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH. Philadelphia, Saunders. 2009, pp 295-306.
3 Smith PP, Smith CP. Botulinum toxin in the treatment of chronic pelvic pain syndromes In: Botulinum toxin. Therapeutic clinical practice and science. Edited by Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH. Philadelphia, Saunders. 2009, pp 257-68.
4 Hallett M. Potential new therapeutic indications for botulinum neurotoxins. In: Botulinum toxin. Therapeutic clinical practice and science. Edited by Jankovic J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Mayer NH. Philadelphia, Saunders. 2009, pp 367-72.
5 Difazio M, Jabbari B. A focused review of the use of botulinum toxins for low back pain. Clin J Pain 2002; 18(Suppl 6): S155-62.   DOI
6 Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache 2000; 40: 445-50.   DOI   ScienceOn
7 Silberstein SD, Gobel H, Jensen R, Elkind AH, Degryse R, Walcott JM, et al. Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study. Cephalalgia 2006; 26: 790-800.   DOI   ScienceOn
8 Evers S, Vollmer-Haase J, Schwaag S, Rahmann A, Husstedt IW, Frese A. Botulinum toxin A in the prophylactic treatment of migraine--a randomized, double-blind, placebocontrolled study. Cephalalgia 2004; 24: 838-43.
9 Smuts JA, Schultz D, Barnard A. Mechanism of action of botulinum toxin type A in migraine prevention: a pilot study. Headache 2004; 44: 801-5.   DOI   ScienceOn
10 Lang AM. Botulinum toxin type B in piriformis syndrome. Am J Phys Med Rehabil 2004; 83: 198-202.   DOI   ScienceOn
11 Gobel H, Heinze A, Reichel G, Hefter H, Benecke R; Dysport myofascial pain study group. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain 2006; 125: 82-8.   DOI   ScienceOn
12 von Lindern JJ, Niederhagen B, Berge S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg 2003; 61: 774-8.   DOI   ScienceOn
13 Babcock MS, Foster L, Pasquina P, Jabbari B. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil 2005; 84: 649-54.   DOI   ScienceOn
14 Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology 2001; 56: 1290-3.   DOI   ScienceOn
15 Gobel H, Heinze A, Heinze-Kuhn K, Austermann K. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain 2001; 91: 195-9.   DOI   ScienceOn
16 Apostol C, Abdi S, Moeller-Bertram T, Smith HS, Argoff CE, Wallace M. Botulinum toxins for the treatment of pain. In: Current therapy in pain. Edited by Smith HS. Philadelphia, Saunders. 2009, pp 489-98.
17 Arezzo JC. Possible mechanisms for the effects of botulinum toxin on pain. Clin J Pain 2002; 18(Suppl 6): S125-32.   DOI
18 Sycha T, Samal D, Chizh B, Lehr S, Gustorff B, Schnider P, et al. A lack of antinociceptive or antiinflammatory effect of botulinum toxin A in an inflammatory human pain model. Anesth Analg 2006; 102: 509-16.   DOI   ScienceOn
19 Kamanli A, Kaya A, Ardicoglu O, Ozgocmen S, Zengin FO, Bayik Y. Comparison of lidocaine injection, Botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome. Rheumatol Int 2005; 25: 604-11.   DOI   ScienceOn
20 Fishman LM, Konnoth C, Rozner B. Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study. Am J Phys Med Rehabil 2004; 83: 42-50.   DOI   ScienceOn
21 Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain 2002; 18(Suppl 6): S142-6.   DOI
22 Colhado OC, Boeing M, Ortega LB. Botulinum toxin in pain treatment. Rev Bras Anestesiol 2009; 59: 366-81.   DOI
23 Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain 2002; 18(Suppl 6): S119-24.   DOI
24 Freund B, Schwartz M. Temporal relationship of muscle weakness and pain reduction in subjects treated with botulinum toxin A. J Pain 2003; 4: 159-65.   DOI   ScienceOn
25 Comella CL, Jankovic J, Shannon KM, Tsui J, Swenson M, Leurgans S, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005; 65: 1423-9.   DOI   ScienceOn
26 Factor SA, Molho ES, Evans S, Feustel PJ. Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia. Mov Disord 2005; 20: 1152-60.   DOI   ScienceOn